{"id":"W4380874094","doi":"10.1101/2023.06.15.23291418","title":"Personalising Alzheimer’s Disease progression using brain atrophy markers","year":2023,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Biomedical Imaging and Bioengineering; National Research, Development and Innovation Office; Engineering and Physical Sciences Research Council; Genentech; National Institutes of Health; British Heart Foundation; IXICO; H. Lundbeck A/S; Eisai; Weston Brain Institute; ZonMw; F. Hoffmann-La Roche; Agence Nationale de la Recherche; University College London; National Institute on Aging; National Institute for Health and Care Research; U.S. Department of Defense; Eli Lilly and Company; Brain Research UK; EU Joint Programme – Neurodegenerative Disease Research; Ministero della Salute; BioClinica; Biogen; Pfizer; Novartis Pharmaceuticals Corporation; Bristol-Myers Squibb; Medical Research Council; Meso Scale Diagnostics; Alzheimer's Association","keywords":"Atrophy; Normative; Hippocampus; Brain size; Disease; Outlier; Magnetic resonance imaging; Alzheimer's Disease Neuroimaging Initiative; Psychology; Cognitive impairment; Cognition; Neuroscience; Medicine; Pathology; Radiology; Artificial intelligence; Computer science; Political science","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009153642,0.0003835759,0.0004567262,0.0003967798,0.0001884788,0.0001304647,0.0002342366,0.0001860187,0.000460741],"category_scores_gemma":[0.0004270773,0.0003314341,0.0004096235,0.0003050651,0.0001912633,0.0000689366,0.0008781815,0.0008345252,0.0001660043],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001346208,"about_ca_system_score_gemma":0.0006437057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005719205,"about_ca_topic_score_gemma":0.000002105566,"domain_scores_codex":[0.9965889,0.0002742561,0.0003696429,0.0008599099,0.001259933,0.0006473216],"domain_scores_gemma":[0.9982737,0.0001250321,0.000160338,0.0005706989,0.0002418366,0.0006284462],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00103236,0.0002582773,0.9757137,0.0009398449,0.0006463322,0.002160352,0.0001584967,0.00001920645,0.003127393,0.0000147036,0.002416498,0.01351285],"study_design_scores_gemma":[0.00130065,0.000224528,0.9808774,0.003472233,0.001298663,0.00002297077,0.0001989607,0.008324545,0.0007276786,0.0004369354,0.002639921,0.0004755365],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883512,0.001868302,0.0004654445,0.005913256,0.0006510529,0.001557181,0.00005453293,0.0002656073,0.0008734472],"genre_scores_gemma":[0.9950675,0.0001301348,0.001390884,0.0004709307,0.0006296484,0.000148362,0.0003339717,0.0001338349,0.001694672],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01303731,"threshold_uncertainty_score":0.9999138,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09749923391002596,"score_gpt":0.4031940816257485,"score_spread":0.3056948477157226,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}